Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of tau gene polymorphism with Parkinson's disease.
Zappia M, Annesi G, Nicoletti G, Serra P, Arabia G, Pugliese P, Messina D, Caracciolo M, Romeo N, Annesi F, Pasqua AA, Spadafora P, Civitelli D, Romeo N, Epifanio A, Morgante L, Quattrone A. Zappia M, et al. Among authors: caracciolo m. Neurol Sci. 2003 Oct;24(3):223-4. doi: 10.1007/s10072-003-0141-z. Neurol Sci. 2003. PMID: 14600827
Apolipoprotein E polymorphisms and Parkinson's disease.
Oliveri RL, Nicoletti G, Cittadella R, Manna I, Branca D, Zappia M, Gambardella A, Caracciolo M, Quattrone A. Oliveri RL, et al. Among authors: caracciolo m. Neurosci Lett. 1999 Dec 24;277(2):83-6. doi: 10.1016/s0304-3940(99)00853-8. Neurosci Lett. 1999. PMID: 10624815
The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A. Oliveri RL, et al. Among authors: caracciolo m. Mov Disord. 2000 Jan;15(1):127-31. doi: 10.1002/1531-8257(200001)15:1<120::aid-mds1019>3.0.co;2-s. Mov Disord. 2000. PMID: 10634251
Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease.
Messina D, Annesi G, Serra P, Nicoletti G, Pasqua A, Annesi F, Tomaino C, Cirò-Candiano IC, Carrideo S, Caracciolo M, Spadafora P, Zappia M, Savettieri G, Quattrone A. Messina D, et al. Among authors: caracciolo m. Neurology. 2002 Mar 12;58(5):828-9. doi: 10.1212/wnl.58.5.828. Neurology. 2002. PMID: 11889255 No abstract available.
FRAXE intermediate alleles are associated with Parkinson's disease.
Annesi G, Nicoletti G, Tarantino P, Cutuli N, Annesi F, Marco EV, Zappia M, Morgante L, Arabia G, Pugliese P, Condino F, Carrideo S, Civitelli D, Caracciolo M, Romeo N, Spadafora P, Candiano IC, Quattrone A. Annesi G, et al. Among authors: caracciolo m. Neurosci Lett. 2004 Sep 16;368(1):21-4. doi: 10.1016/j.neulet.2004.06.049. Neurosci Lett. 2004. PMID: 15342126
APOE and risk of cognitive impairment in multiple sclerosis.
Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V, Bono F, Caracciolo M, Quattrone A. Oliveri RL, et al. Among authors: caracciolo m. Acta Neurol Scand. 1999 Nov;100(5):290-5. doi: 10.1111/j.1600-0404.1999.tb00398.x. Acta Neurol Scand. 1999. PMID: 10536914
Anti-GM1 ganglioside antibodies in Parkinson's disease.
Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagalà A, Bastone L, Napoli ID, Caracciolo M, Bonavita S, Di Costanzo A, Gambardella A, Quattrone A. Zappia M, et al. Among authors: caracciolo m. Acta Neurol Scand. 2002 Jul;106(1):54-7. doi: 10.1034/j.1600-0404.2002.01240.x. Acta Neurol Scand. 2002. PMID: 12067330 Clinical Trial.
Body weight influences pharmacokinetics of levodopa in Parkinson's disease.
Zappia M, Crescibene L, Arabia G, Nicoletti G, Bagalà A, Bastone L, Caracciolo M, Bonavita S, Di Costanzo A, Scornaienchi M, Gambardella A, Quattrone A. Zappia M, et al. Among authors: caracciolo m. Clin Neuropharmacol. 2002 Mar-Apr;25(2):79-82. doi: 10.1097/00002826-200203000-00004. Clin Neuropharmacol. 2002. PMID: 11981233
91 results